• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA EXCHANGE SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA EXCHANGE SET Back to Search Results
Catalog Number 10220
Device Problems Use of Device Problem (1670); Improper or Incorrect Procedure or Method (2017)
Patient Problem No Patient Involvement (2645)
Event Date 03/04/2019
Event Type  malfunction  
Manufacturer Narrative
Additional information (b)(6).Investigation: the optia essentials guide informs the operator of the following: when preparing to perform a procedure, ensure that the lines are connected to the correct fluids, and that fluid is flowing into the drip chambers: ac line (orange) to the anticoagulant container saline line (green) to the normal saline (0.9%) container.Ac spike is orange and matches the tint of the ac tubing to differentiate it from other spikes on the disposable set.Saline spike is green and matches the tint of the saline tubing to differentiate it from other spikes on the disposable set.Additionally, the software screen prompts are also color coded (orange for ac and green for saline) to differentiate the two and direct the operator to match the color coded spikes.The customer did not provide the lot number pertaining to this event, therefore a device history record (dhr) search could not be conducted for this specific incident.All lots must meet acceptance criteria before release.Investigation is in-process.A follow-up report will be provided.
 
Event Description
The customer reported that during prime on spectra optia they inadvertently spiked anticoagulant on wrong spike.The customer contacted terumo bct support specialist for troubleshooting.Per the operator, during prime she noticed that the anticoagulant was spiked on the wrong line and wanted to know if the lines can be switched to continue the run.The customer also stated that the lines were not primed with the appropriate fluid.The support specialist instructed the operator to unload the disposable set and to discontinue the procedure.The customer did not respond to multiple attempts to obtain information for the investigation such as patient information, procedural details and lot information.Since the error was found during prime, the patient was not connected to device at the time.No adverse events were reported and no medical intervention was necessary as a result of the error.The spectra optia exchange set is not available for return because it was discarded by the customer.
 
Manufacturer Narrative
Correction: at the time of the reported incident, the terumo bct clinical specialist explainedwhy the procedure could not be continued by switching the lines.The operator verbalizedunderstanding.Root cause: the root cause of the anticoagulant being spiked on the wrong line was a failure ofthe operator to follow screen prompts to ensure spiking the correct solution by matching theorange color coded spike with the orange tubing.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPECTRA OPTIA
Type of Device
SPECTRA OPTIA EXCHANGE SET
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
MDR Report Key8464244
MDR Text Key146401457
Report Number1722028-2019-00069
Device Sequence Number1
Product Code LKN
Combination Product (y/n)N
PMA/PMN Number
K172590
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 03/29/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number10220
Was Device Available for Evaluation? No
Was the Report Sent to FDA? Yes
Initial Date Manufacturer Received 03/04/2019
Initial Date FDA Received03/29/2019
Supplement Dates Manufacturer Received03/29/2019
Supplement Dates FDA Received04/02/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-